| Literature DB >> 35314832 |
Md Abdul Mazid1,2, Carl Ward3, Zhiwei Luo3, Chuanyu Liu4, Yunpan Li3, Yiwei Lai3,4, Liang Wu5,4, Jinxiu Li5,4, Wenqi Jia3,5, Yu Jiang6, Hao Liu3, Lixin Fu3,5, Yueli Yang6, David P Ibañez3,5, Junjian Lai3, Xiaoyu Wei5,4, Juan An3,7, Pengcheng Guo6, Yue Yuan5,4, Qiuting Deng5,4, Yang Wang4, Ying Liu4, Fei Gao8, Junwen Wang9, Shahriar Zaman10, Baoming Qin11, Guangming Wu12, Patrick H Maxwell13, Xun Xu4,14, Longqi Liu15, Wenjuan Li16, Miguel A Esteban17,18,19,20.
Abstract
After fertilization, the quiescent zygote experiences a burst of genome activation that initiates a short-lived totipotent state. Understanding the process of totipotency in human cells would have broad applications. However, in contrast to in mice1,2, demonstration of the time of zygotic genome activation or the eight-cell (8C) stage in in vitro cultured human cells has not yet been reported, and the study of embryos is limited by ethical and practical considerations. Here we describe a transgene-free, rapid and controllable method for producing 8C-like cells (8CLCs) from human pluripotent stem cells. Single-cell analysis identified key molecular events and gene networks associated with this conversion. Loss-of-function experiments identified fundamental roles for DPPA3, a master regulator of DNA methylation in oocytes3, and TPRX1, a eutherian totipotent cell homeobox (ETCHbox) family transcription factor that is absent in mice4. DPPA3 induces DNA demethylation throughout the 8CLC conversion process, whereas TPRX1 is a key executor of 8CLC gene networks. We further demonstrate that 8CLCs can produce embryonic and extraembryonic lineages in vitro or in vivo in the form of blastoids5 and complex teratomas. Our approach provides a resource to uncover the molecular process of early human embryogenesis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35314832 DOI: 10.1038/s41586-022-04625-0
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962